XML 21 R14.htm IDEA: XBRL DOCUMENT
v3.25.3

Marketable Securities | 9 Months Ended
--- | ---
Sep. 30, 2025
Marketable Securities [Abstract] |
Marketable Securities | 4. Marketable Securities The following tables summarize the available-for-sale debt securities held at September 30, 2025 and December 31, 2024 (in thousands):
Description |  | Amortized Cost |  |  | Unrealized Gains |  |  | Unrealized Losses |  |  | Fair Value |
September 30, 2025 |  |  |  |  |  |  |  |  |  |  |  |
US treasury securities |  | $ | 188,647 |  |  | $ | 479 |  |  | $ | (28 | ) |  | $ | 189,098 |
US government agencies |  |  | 222,856 |  |  |  | 181 |  |  |  | (145 | ) |  |  | 222,892 |
Commercial Paper |  |  | 10,683 |  |  |  | 1 |  |  |  | — |  |  |  | 10,684 |
Corporate securities |  |  | 442,099 |  |  |  | 1,091 |  |  |  | (77 | ) |  |  | 443,113 |
Total |  | $ | 864,285 |  |  | $ | 1,752 |  |  | $ | (250 | ) |  | $ | 865,787 |
Description |  | Amortized Cost |  |  | Unrealized Gains |  |  | Unrealized Losses |  |  | Fair Value |
December 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |
US treasury securities |  | $ | 158,518 |  |  | $ | 190 |  |  | $ | (244 | ) |  | $ | 158,464 |
US government agencies |  |  | 179,030 |  |  |  | 33 |  |  |  | (1,248 | ) |  |  | 177,815 |
Commercial Paper |  |  | 15,847 |  |  |  | 5 |  |  |  | — |  |  |  | 15,852 |
Corporate securities |  |  | 378,736 |  |  |  | 424 |  |  |  | (644 | ) |  |  | 378,516 |
Total |  | $ | 732,131 |  |  | $ | 652 |  |  | $ | (2,136 | ) |  | $ | 730,647 |
As of September 30, 2025, the Company held 51 securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $143.3 million. As of December 31, 2024, the Company held 121 securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $342.1 million. As of September 30, 2025, the Company held 24 securities that had been in an unrealized loss position for greater than 12 months with an aggregate fair value of $72.1 million. As of December 31, 2024, the Company held 4 securities that had been in an unrealized loss position for greater than 12 months with an aggregate fair value of $7.6 million. As of September 30, 2025 the Company had 124 securities with a fair value of $392.7 million with a contractual maturity of less than 12 months and 166 securities with a fair value of $473.1 million with a contractual maturity of greater than 12 months. As of December 31, 2024, the Company had 129 securities with a fair value of $368.5 million with a contractual maturity of less than 12 months and 116 securities with a fair value of $362.2 million with a contractual maturity of greater than 12 months. The Company is required to determine whether a decline in the fair value below the amortized cost basis of available-for-sale securities is due to credit-related factors. At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company’s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer’s industry, and any significant deterioration in economic conditions. Unrealized losses on available-for-sale securities presented in the previous table have not been recognized in the condensed consolidated statements of operations because the securities are high credit quality, investment grade securities that the Company does not intend to sell and will not be required to sell prior to their anticipated recovery, and the decline in fair value is attributable to factors other than credit losses. Based on its evaluation, the Company determined it does no t have any credit losses related to its available-for-sale securities as of September 30, 2025 and December 31, 2024.

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 940 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/940-320/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph b -Publisher SEC Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/942-320/tableOfContent + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_MarketableSecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration